Cyclacel Pharmaceuticals (CYCC)

Create an Alert
3.12 -0.04  -1.27%   NASDAQ Jun 18, 8:00PM BATS Real time Currency in USD

Cyclacel Pharmaceuticals Cash and ST Investments:

14.14M for March 31, 2013
View Full Chart

Cyclacel Pharmaceuticals Cash and ST Investments Chart

    Cyclacel Pharmaceuticals Historical Cash and ST Investments Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 14.14M
    Dec. 31, 2012 16.41M
    Sept. 30, 2012 17.84M
    June 30, 2012 19.96M
    March 31, 2012 23.64M
    Dec. 31, 2011 24.45M
    Sept. 30, 2011 27.68M
    June 30, 2011 20.61M
    March 31, 2011 25.35M
    Dec. 31, 2010 29.50M
    Sept. 30, 2010 18.48M
    June 30, 2010 19.54M
    March 31, 2010 24.20M
    Dec. 31, 2009 11.49M
    Sept. 30, 2009 14.43M
    June 30, 2009 15.86M
    March 31, 2009 20.44M
    Dec. 31, 2008 25.72M
    Sept. 30, 2008 33.72M
       
    June 30, 2008 39.97M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro

    About Cash and Short Term Investments

    Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

    Cash and short term investments are considered very liquid assets. For instance, if a company needs immediate liquidity, cash and short term investments can be be quickly used. Cash and short term investments are frequently used in liquidity ratios.
    Learn More

    Get data for

    CYCC Cash and ST Investments Benchmarks

    Companies
    Alkermes 221.35M
    3SBio 138.12M
    Exelixis 356.56M

    CYCC Cash and ST Investments Rankings

    Overall 65th percentile
    5747 of 16773
    Sector 61st percentile
    541 of 1408 in Healthcare
    Industry 57th percentile
    194 of 453 in Biotechnology

    CYCC Cash and ST Investments Range, Past 5 Years

    Minimum 11.49M Dec 2009
    Maximum 39.97M Jun 2008
    Average 22.17M

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');